Results 131 to 140 of about 20,887 (223)

MYCN Gene [PDF]

, 2020
openaire   +1 more source

MYCN oncoprotein targets and their therapeutic potential

The MYCN oncogene encodes a transcription factor which is amplified in up to 40% of high risk neuroblastomas. MYCN amplification is a well-established poor prognostic marker in neuroblastoma, however the role of MYCN expression and the mechanisms by ...
Chen LD, Tweddle DA, Lunec J, Marshall GM, Bell E, Liu T   +5 more
core   +2 more sources

Oncogene MYCN [PDF]

, 2020
openaire   +1 more source

Immune remodeling and myeloid signature in the bone marrow niche of MYCN-driven neuroblastoma. [PDF]

BJC Rep
Embaie BT, Alchahin AM, Velentza L, Olsen TK, Gavriliuc IM, Mei S, Baryawno N.   +6 more
europepmc   +1 more source

MYCN Positive [PDF]

, 2020
openaire   +1 more source

Targeting MYCN Degradation by HLB-0532259 Induces Senescence in Retinoblastoma. [PDF]

Invest Ophthalmol Vis Sci
Tang J, Zhang Z, Lv J, Wang M, Sun H, Yao L, Li J, Liu Y, Huang W, Gao Y, Zhu Y, Su S, Lu R.   +12 more
europepmc   +1 more source

MYCN Negative [PDF]

, 2020
openaire   +1 more source

Comparative Functional Effects of Abemaciclib and Arcyriaflavin A in <i>MYCN</i>-Amplified and Non-Amplified Neuroblastoma Cells: An Exploratory Transcriptomic Study. [PDF]

Int J Mol Sci
Çerçi B, Karahan Hİ, Soyöz M, Pehlivan M, Pirim İ.   +4 more
europepmc   +1 more source

Targeting MYC-Driven Cancers: From Oncogenic Addiction to Therapeutic Vulnerability. [PDF]

BioDrugs
Sainero-Alcolado L, Lama D, Alzrigat M, Arsenian-Henriksson M.   +3 more
europepmc   +1 more source

Triple-amplified sequential activation allosteric DNA biosensor for <i>in vivo</i> quantitative detection of <i>MYCN</i> copy number in neuroblastoma. [PDF]

RSC Adv
Zhao L, Zhang Y, Tian H, Zhang M, Liu K, Sun M, Li Z, Hou L, Zhang X, Zhang W.   +9 more
europepmc   +1 more source